JMU Alumnus Arber Shehu Earns National Recognition for His Work in Oncology and Medical Affairs

News
 
Arber Shehu

SUMMARY: Arber Shehu, a JMU graduate with a Master’s in Health Sciences, was named to the MM+M 40 Under 40 Class of 2025 for his work in oncology and medical affairs. He leads efforts at AstraZeneca to improve lung cancer treatment and has made a significant impact in public health.


Arber Shehu, a James Madison University (JMU) graduate with a Master’s in Health Sciences, was recently acknowledged for his contributions to medical affairs and oncology treatment. Arber was recognized as part of the MM+M 40 Under 40 Class of 2025! MM+M (Medical Marketing + Media) is one of the most prestigious platforms in healthcare marketing. The 40 Under 40 Award recognizes individuals who are making a significant impact in medical marketing and healthcare communications through innovation, strategy, and leadership. Arber credits JMU for laying the foundation for his career and contributing to the achievements that led to this recognition.

Arber is a Medical Director in U.S. Medical Affairs for Lung Cancer Targeted Therapy at AstraZeneca, where he leads the development and execution of medical strategies that align with scientific data, regulatory requirements, and commercial objectives to improve patient care. His work involves close collaboration with cross-functional teams, leaders in this field, and support for clinical research, medical education, and real-world evidence generation to advance lung cancer treatment and give patients access to innovative therapies.

Arber’s recognition is the culmination of multiple achievements across different phases of his career. Earlier in his career, Arber helped provide medical care and access to critical healthcare services to underserved populations in Kosovo. Later, as a researcher at Johns Hopkins School of Medicine, Arber co-led efforts to assess the effectiveness of COVID-19 vaccines to prevent hospitalization, ICU admissions, and mortality. This work directly informed public health recommendations that helped shape national and global health policies. And, after joining AstraZeneca, Arber helped expand treatment options for patients with EGFR-mutated non-small cell lung cancer (NSCLC). Arber also was the head initiator of initiatives at AstraZeneca to empower patients and enhance lung cancer screening strategies.

While at JMU, Arber gained various skills that he now applies daily in his work. Arber researched on the impact of physical activity on cardiovascular disease outcomes. This work deepened his understanding of research methodology, evidence-based medicine, and the role of healthcare professionals in the shaping of patient outcomes. He also developed scientific writing and communication, interpersonal, collaboration, community engagement, and leadership skills.

For Arber this recognition is a testament to hard work, perseverance, and the belief in pushing beyond self-imposed boundaries. It also reinforces his commitment to advance oncology treatment, support research-driven decision-making, and help shape the future of healthcare through collaborations and innovation.

Arber’s advice to students interested this field “If you aspire to work in medical affairs, oncology, or public health, invest in continuous learning, adaptability, and cross-functional collaboration. Always stay curious, resilient, and committed to making a meaningful impact on patient care and scientific advancement.”

Back to Top

by Dardanë Halimi

Published: Thursday, February 20, 2025

Last Updated: Thursday, February 20, 2025

Related Articles